With use of molecular diagnostics tests widely expected to skyrocket in the coming decade, UnitedHealth Group is getting increasingly nervous about the trend and looking for ways to manage their use and expense.
A Philadelphia judge has opened the door for UnitedHealth to file subrogation claims against GlaxoSmithKline on behalf of some of its members who may have been injured by the drugmaker's products.
UnitedHealth is ramping up a reimbursement test that could have long-term effects on sales of the most expensive cancer drugs. The insurer will test a payment system that reimburses oncologists for
More pressure on Merck's cholesterol franchise: UnitedHealth Group is doubling the co-pays on Zetia and Vytorin. Beginning July 1, patients will have to pay $50 to $60 for those cholesterol
Remember that drug-safety database Congress required the FDA to set up? The idea was for the FDA to actively monitor drugs and possible adverse effects, rather than waiting for doctors and drug
Expect the FDA to stay out of the Vytorin fray , at least for now. So Janet Woodcock (
We didn't have to wait long for a Vytorin decision Â from UnitedHealth Group. The largest U.S. insurer says